Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC Cream in Psoriasis Vulgaris
NCT07426120Phase 3Recruiting
- Sponsor
- Psoriasis Research Institute of Guangzhou
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of coumarin in Psoriasis vulgaris (PV) (2 arms), sponsored by Psoriasis Research Institute of Guangzhou. Primary endpoint: Investigator's Global Assessment at 12 weeks. Started Feb 2026; status: recruiting.
02
Drugs
coumarin
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT07426120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07426120.